LGALS3 and pulmonary arterial hypertension: Barman et al. demonstrated a direct correlation between the galectin-3 levels and the pulmonary vascular remodeling using galectin-3 KO mice or using GM-CT-01 and GR-MD-02 inhibitors using an animal model of PAH (124).